Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.22 -0.05 (-1.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Short term Debt (2018)

Updated

Adial Pharmaceuticals (ADIL) recorded Short term Debt of $138,603 in Q3 2018, up 383.3% from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Short term Debt (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Adial Pharmaceuticals 19.23 Mn -24.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 138,603.00
Jun 30, 2018 28,676.00
API Access

Adial Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ADIL&period=max&api_key=YOUR_API_KEY